First National Bank of South Miami’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4
Closed 270
2022
Q2
$0 Hold
4
﹤0.01% 302
2022
Q1
$0 Hold
4
﹤0.01% 341
2021
Q4
$0 Hold
4
﹤0.01% 361
2021
Q3
$1K Hold
4
﹤0.01% 333
2021
Q2
$1K Buy
+4
New +$1.21K ﹤0.01% 326
2020
Q3
Sell
-15
Closed -$4K 272
2020
Q2
$4K Hold
15
﹤0.01% 258
2020
Q1
$5K Hold
15
0.01% 242
2019
Q4
$4K Hold
15
﹤0.01% 248
2019
Q3
$3K Hold
15
﹤0.01% 264
2019
Q2
$4K Buy
+15
New +$3.46K ﹤0.01% 265

Other funds holding BIIB

First National Bank of South Miami's BIIB Position: Q3 2022 in Review

First National Bank of South Miami sold out of Biogen (BIIB) in Q3 2022, closing a stake of 4 shares.

First National Bank of South Miami first reported a position in BIIB in Q2 2019 and held it in 10 quarters. The position peaked at $5K in Q1 2020. 987 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • First National Bank of South Miami reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
  • First National Bank of South Miami sold 4 Biogen shares in Q3 2022.
  • First National Bank of South Miami first reported a position in Biogen in Q2 2019 and held it in 10 quarters.
  • First National Bank of South Miami's Biogen position peaked at $5K in Q1 2020.
  • 987 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on First National Bank of South Miami's 13F filing for Q3 2022, filed 31 Oct 2022.